Roy de Souza
Company: BreakBio
Job title: Chief Executive Officer & Co-Founder
Seminars:
Employing Mass Spectrometry per Patient Combined with Machine Learning to Find the Best Targets 9:00 am
Using mass spectrometry to find presented antigens per patient for a targeted, personalized vaccine Creating software with AI/machine learning to find cancer vaccine targets based on DNA mutations, RNA expression, and mass spectrometry per patient Searching for the best targets in low tumor mutational burden cancers for the most effective personalized cancer vaccinesRead more
day: Pre-Conference Focus Day